Novel Drug Reverses Alzheimer’s-induced Loss of Brain Connections

The Sanford-Burnham Medical Research Institute has developed a drug that brings the Alzheimer’s-triggered loss of brain connection to a halt. NitroMemantine is the combination of two FDA-approved drugs, and it boosts lost brain synapses. the findings, published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS), suggest that doctors may be able to treat the disease a little later than expected. Click here to read the full story.